In a world where the integrity of pharmaceutical products is critical to public health, a young Indian startup is taking a bold step toward eliminating one of the industry’s most persistent threats: counterfeit medicines. Meet AltiusHub, a Hyderabad-based company on a mission to revolutionize supply chain transparency in pharma manufacturing through advanced tracking technologies and intelligent anomaly detection systems.
Founded in 2023 by industry insiders Siddharth Reddy and Abiram Vijaykumar, AltiusHub was born from a deep understanding of the blind spots that plague pharma logistics. Both founders bring years of combined experience in pharmaceutical operations and supply chain management, giving them a unique vantage point to address one of the industry’s most urgent challenges—ensuring that every pill, vial, and bottle is genuine, safe, and traceable.
Just a year into its journey, the startup has secured US$2.25 million in seed funding, led by Endiya Partners, a prominent early-stage venture capital firm known for backing transformative deeptech and healthtech innovations in India. The capital will be primarily used to scale AltiusHub’s engineering capabilities and onboard new talent—a critical move as the company looks to expand its technological offerings and deepen its market footprint.
A Mission Fueled by Urgency
Counterfeit medicines remain a deadly global issue, particularly in emerging markets. According to the World Health Organization, an estimated 1 in 10 medical products in low- and middle-income countries is substandard or falsified. The consequences are not just economic—they can be fatal.
AltiusHub’s platform offers a real-time, intelligent tracking system that integrates directly into pharmaceutical production and logistics workflows. By using AI and data analytics, it flags suspicious patterns—such as abnormal distribution timelines, duplicate codes, or unscheduled stops—that could indicate diversion or counterfeiting.
“Our technology isn’t just about barcodes or blockchain,” says Siddharth Reddy, co-founder and CEO. “It’s about building a living, breathing map of the pharma supply chain where every movement is tracked, and every irregularity is instantly flagged—before it becomes a crisis.”
The system is designed to be modular and scalable, allowing manufacturers, distributors, and regulatory bodies to plug in and get visibility across the lifecycle of a drug—from the production line to the pharmacy shelf.
Building India’s Intelligent Pharma Backbone
AltiusHub’s platform doesn’t only help detect counterfeit activity—it also provides valuable data insights for optimizing operations. For example, companies can identify inefficiencies in transportation routes, monitor cold chain compliance, and predict potential bottlenecks based on past trends.
“We’re not just fighting counterfeits,” adds Abiram Vijaykumar, co-founder and COO. “We’re helping pharma companies future-proof their supply chains in a hyper-regulated, increasingly complex market.”
This holistic approach resonates with a pharma industry that is under pressure to be faster, more transparent, and globally compliant. The startup’s timing is impeccable—India, often dubbed the “pharmacy of the world,” has seen growing demand for digital supply chain solutions, particularly post-pandemic.
What’s Next for AltiusHub?
With fresh capital in hand and a clear vision for the future, AltiusHub is poised to become a key player in India’s healthtech and logistics ecosystem. The startup plans to expand its presence across major pharma manufacturing hubs in India, with pilot deployments already underway.
Beyond India, the company is also eyeing partnerships in regions with high counterfeit risk, including parts of Africa, Southeast Asia, and Latin America, where lack of infrastructure often allows fake drugs to slip through the cracks.
As AltiusHub continues to grow, it aims to become more than just a solution provider—it envisions becoming a trust layer for the global pharma supply chain.
In an era where health outcomes are increasingly dependent on the integrity of complex supply networks, AltiusHub’s innovation-driven approach offers hope—not just for pharmaceutical companies, but for millions of patients whose lives depend on the authenticity of every dose they take.